Penserra Capital Management LLC Protagonist Therapeutics, Inc Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$17.63 - $37.1 $19,216 - $40,439	-1,090 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$12.95 - $49.69 $1,165 - $4,472	90 Added 9.0%	1,090 $19,000
Q2 2021 Aug 12, 2021	BUY	$25.57 - $44.88 $767 - $1,346	30 Added 3.09%	1,000 $44,000
Q1 2021 May 13, 2021	BUY	$19.02 - $31.15 $1,711 - $2,803	90 Added 10.23%	970 $25,000
Q4 2020 Feb 12, 2021	BUY	$18.49 - $25.13 $10,428 - $14,173	564 Added 178.48%	880 $17,000
Q3 2020 Nov 13, 2020	BUY	$15.19 - $22.4 $4,800 - $7,078	316 New	316 $6,000

212

59.1M

19K

107K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.25B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.